nodes	percent_of_prediction	percent_of_DWPC	metapath
Levonordefrin—SLC6A2—locus ceruleus—Parkinson's disease	0.0632	0.188	CbGeAlD
Levonordefrin—SLC6A2—sympathetic nervous system—Parkinson's disease	0.0499	0.149	CbGeAlD
Levonordefrin—SLC6A2—autonomic nervous system—Parkinson's disease	0.0336	0.1	CbGeAlD
Levonordefrin—SLC6A2—nerve—Parkinson's disease	0.0189	0.0562	CbGeAlD
Levonordefrin—ADRA2A—peripheral nervous system—Parkinson's disease	0.0171	0.051	CbGeAlD
Levonordefrin—Carbidopa—DDC—Parkinson's disease	0.0152	0.193	CrCbGaD
Levonordefrin—ADRA1A—hindbrain—Parkinson's disease	0.0132	0.0392	CbGeAlD
Levonordefrin—Methyldopa—DDC—Parkinson's disease	0.00814	0.103	CrCbGaD
Levonordefrin—SLC6A2—brainstem—Parkinson's disease	0.00811	0.0241	CbGeAlD
Levonordefrin—SLC6A2—forebrain—Parkinson's disease	0.00782	0.0233	CbGeAlD
Levonordefrin—ADRA1A—brainstem—Parkinson's disease	0.00754	0.0224	CbGeAlD
Levonordefrin—ADRA1A—forebrain—Parkinson's disease	0.00727	0.0217	CbGeAlD
Levonordefrin—ADRA1A—cardiovascular system—Parkinson's disease	0.00615	0.0183	CbGeAlD
Levonordefrin—Isoprenaline—ADRBK1—Parkinson's disease	0.00581	0.0735	CrCbGaD
Levonordefrin—SLC6A2—medulla oblongata—Parkinson's disease	0.00565	0.0168	CbGeAlD
Levonordefrin—ADRA2A—forebrain—Parkinson's disease	0.00553	0.0165	CbGeAlD
Levonordefrin—Dopamine—DBH—Parkinson's disease	0.00525	0.0663	CrCbGaD
Levonordefrin—Droxidopa—DDC—Parkinson's disease	0.00508	0.0642	CrCbGaD
Levonordefrin—ADRA2C—medulla oblongata—Parkinson's disease	0.00501	0.0149	CbGeAlD
Levonordefrin—Epinephrine—ADRBK1—Parkinson's disease	0.00489	0.0617	CrCbGaD
Levonordefrin—ADRA2C—midbrain—Parkinson's disease	0.00458	0.0136	CbGeAlD
Levonordefrin—SLC6A2—head—Parkinson's disease	0.00448	0.0133	CbGeAlD
Levonordefrin—ADRA2C—spinal cord—Parkinson's disease	0.00447	0.0133	CbGeAlD
Levonordefrin—L-DOPA—DDC—Parkinson's disease	0.00428	0.0541	CrCbGaD
Levonordefrin—SLC6A2—nervous system—Parkinson's disease	0.00425	0.0126	CbGeAlD
Levonordefrin—ADRA1A—head—Parkinson's disease	0.00417	0.0124	CbGeAlD
Levonordefrin—SLC6A2—central nervous system—Parkinson's disease	0.00409	0.0122	CbGeAlD
Levonordefrin—ADRA2A—medulla oblongata—Parkinson's disease	0.004	0.0119	CbGeAlD
Levonordefrin—ADRA2C—head—Parkinson's disease	0.00397	0.0118	CbGeAlD
Levonordefrin—ADRA1A—nervous system—Parkinson's disease	0.00395	0.0118	CbGeAlD
Levonordefrin—ADRA1A—central nervous system—Parkinson's disease	0.0038	0.0113	CbGeAlD
Levonordefrin—ADRA2C—nervous system—Parkinson's disease	0.00376	0.0112	CbGeAlD
Levonordefrin—ADRA1A—cerebellum—Parkinson's disease	0.00372	0.0111	CbGeAlD
Levonordefrin—ADRA2A—midbrain—Parkinson's disease	0.00365	0.0109	CbGeAlD
Levonordefrin—Methyldopa—COMT—Parkinson's disease	0.00364	0.046	CrCbGaD
Levonordefrin—ADRA2C—central nervous system—Parkinson's disease	0.00362	0.0108	CbGeAlD
Levonordefrin—ADRA2A—spinal cord—Parkinson's disease	0.00356	0.0106	CbGeAlD
Levonordefrin—ADRA2C—cerebellum—Parkinson's disease	0.00354	0.0105	CbGeAlD
Levonordefrin—SLC6A2—brain—Parkinson's disease	0.00325	0.00967	CbGeAlD
Levonordefrin—ADRA2A—head—Parkinson's disease	0.00317	0.00943	CbGeAlD
Levonordefrin—ADRA1A—brain—Parkinson's disease	0.00302	0.00899	CbGeAlD
Levonordefrin—ADRA2A—nervous system—Parkinson's disease	0.003	0.00894	CbGeAlD
Levonordefrin—Norepinephrine—SLC18A2—Parkinson's disease	0.00299	0.0379	CrCbGaD
Levonordefrin—ADRA2A—central nervous system—Parkinson's disease	0.00289	0.00861	CbGeAlD
Levonordefrin—ADRA2C—brain—Parkinson's disease	0.00288	0.00856	CbGeAlD
Levonordefrin—ADRA2A—cerebellum—Parkinson's disease	0.00283	0.00841	CbGeAlD
Levonordefrin—ADRA2A—brain—Parkinson's disease	0.0023	0.00683	CbGeAlD
Levonordefrin—Dopamine—MAOB—Parkinson's disease	0.00191	0.0241	CrCbGaD
Levonordefrin—Phenylpropanolamine—MAOA—Parkinson's disease	0.00186	0.0236	CrCbGaD
Levonordefrin—Dopamine—COMT—Parkinson's disease	0.00178	0.0224	CrCbGaD
Levonordefrin—Phenylpropanolamine—DRD1—Parkinson's disease	0.0017	0.0214	CrCbGaD
Levonordefrin—Phenylpropanolamine—SLC6A3—Parkinson's disease	0.00161	0.0203	CrCbGaD
Levonordefrin—Dopamine—MAOA—Parkinson's disease	0.00134	0.0169	CrCbGaD
Levonordefrin—L-DOPA—DRD3—Parkinson's disease	0.00133	0.0169	CrCbGaD
Levonordefrin—Dopamine—HTR7—Parkinson's disease	0.00132	0.0167	CrCbGaD
Levonordefrin—L-DOPA—DRD1—Parkinson's disease	0.00131	0.0166	CrCbGaD
Levonordefrin—Dopamine—DRD3—Parkinson's disease	0.00124	0.0157	CrCbGaD
Levonordefrin—Dopamine—DRD1—Parkinson's disease	0.00122	0.0154	CrCbGaD
Levonordefrin—Dopamine—SLC6A3—Parkinson's disease	0.00115	0.0146	CrCbGaD
Levonordefrin—Epinephrine—TNF—Parkinson's disease	0.00105	0.0132	CrCbGaD
Levonordefrin—Dopamine—HTR1A—Parkinson's disease	0.00101	0.0128	CrCbGaD
Levonordefrin—Norepinephrine—DRD2—Parkinson's disease	0.000924	0.0117	CrCbGaD
Levonordefrin—L-DOPA—DRD2—Parkinson's disease	0.000924	0.0117	CrCbGaD
Levonordefrin—Dopamine—DRD2—Parkinson's disease	0.000859	0.0109	CrCbGaD
Levonordefrin—L-DOPA—CYP2D6—Parkinson's disease	0.000653	0.00825	CrCbGaD
Levonordefrin—Dopamine—CYP2D6—Parkinson's disease	0.000607	0.00767	CrCbGaD
Levonordefrin—ADRA2A—Signaling by GPCR—PDYN—Parkinson's disease	0.000363	0.000621	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR downstream signaling—HTR1A—Parkinson's disease	0.000362	0.000618	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000358	0.000613	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—RIT2—Parkinson's disease	0.000358	0.000613	CbGpPWpGaD
Levonordefrin—ADRA2C—Hemostasis—HGF—Parkinson's disease	0.000358	0.000612	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR downstream signaling—TAC1—Parkinson's disease	0.000356	0.000609	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR ligand binding—HTR2A—Parkinson's disease	0.000354	0.000605	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR ligand binding—EDN1—Parkinson's disease	0.000354	0.000605	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—ADORA2A—Parkinson's disease	0.000354	0.000604	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR downstream signaling—DRD1—Parkinson's disease	0.000349	0.000597	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.00034	0.000582	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—GRK5—Parkinson's disease	0.00034	0.000581	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR downstream signaling—DRD3—Parkinson's disease	0.000338	0.000578	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—HTR1A—Parkinson's disease	0.000338	0.000577	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—GRM5—Parkinson's disease	0.000338	0.000577	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—DDC—Parkinson's disease	0.000335	0.000572	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000333	0.000569	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—TAC1—Parkinson's disease	0.000333	0.000569	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR ligand binding—EDN1—Parkinson's disease	0.000329	0.000562	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—HTR1A—Parkinson's disease	0.000328	0.000561	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—DRD1—Parkinson's disease	0.000326	0.000558	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—GRM4—Parkinson's disease	0.000326	0.000558	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—SOD1—Parkinson's disease	0.000324	0.000554	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—TAC1—Parkinson's disease	0.000323	0.000553	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—DRD1—Parkinson's disease	0.000317	0.000542	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.000316	0.000541	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—DRD3—Parkinson's disease	0.000316	0.00054	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—GSTA4—Parkinson's disease	0.000316	0.00054	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000316	0.00054	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—RIT2—Parkinson's disease	0.000313	0.000536	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR ligand binding—HTR2A—Parkinson's disease	0.00031	0.000529	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—PENK—Parkinson's disease	0.000309	0.000529	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—MAG—Parkinson's disease	0.000309	0.000529	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—ABL1—Parkinson's disease	0.000309	0.000528	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—ADORA2A—Parkinson's disease	0.000309	0.000528	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—IGF2—Parkinson's disease	0.000308	0.000526	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—DRD3—Parkinson's disease	0.000307	0.000525	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—HTR1A—Parkinson's disease	0.000307	0.000524	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR downstream signaling—HTR7—Parkinson's disease	0.000306	0.000523	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR downstream signaling—DRD2—Parkinson's disease	0.000306	0.000523	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—GRM4—Parkinson's disease	0.000305	0.000521	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—TAC1—Parkinson's disease	0.000302	0.000516	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—GRK5—Parkinson's disease	0.000297	0.000508	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—DRD1—Parkinson's disease	0.000296	0.000506	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—HTR1A—Parkinson's disease	0.000295	0.000505	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000295	0.000504	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—RIT2—Parkinson's disease	0.000291	0.000498	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—TAC1—Parkinson's disease	0.000291	0.000497	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—HGF—Parkinson's disease	0.000291	0.000497	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—PENK—Parkinson's disease	0.000289	0.000494	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—MAG—Parkinson's disease	0.000289	0.000494	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR ligand binding—HTR2A—Parkinson's disease	0.000288	0.000492	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—ADORA2A—Parkinson's disease	0.000287	0.000491	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—DRD3—Parkinson's disease	0.000287	0.000491	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000287	0.00049	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—DRD2—Parkinson's disease	0.000286	0.000488	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—HTR7—Parkinson's disease	0.000286	0.000488	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—DRD1—Parkinson's disease	0.000285	0.000488	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—PLA2G6—Parkinson's disease	0.000285	0.000486	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—PDYN—Parkinson's disease	0.000283	0.000484	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—MAOB—Parkinson's disease	0.000282	0.000481	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—HTR7—Parkinson's disease	0.000278	0.000475	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—DRD2—Parkinson's disease	0.000278	0.000475	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—DRD3—Parkinson's disease	0.000276	0.000472	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—GRK5—Parkinson's disease	0.000276	0.000472	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—HTR1A—Parkinson's disease	0.000274	0.000469	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—DDC—Parkinson's disease	0.000272	0.000465	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—TAC1—Parkinson's disease	0.00027	0.000462	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—HTR1A—Parkinson's disease	0.000268	0.000458	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000268	0.000458	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—GRM4—Parkinson's disease	0.000266	0.000455	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—GFAP—Parkinson's disease	0.000266	0.000455	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—DRD1—Parkinson's disease	0.000265	0.000453	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—PDYN—Parkinson's disease	0.000264	0.000452	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—TAC1—Parkinson's disease	0.000264	0.000451	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—GRM5—Parkinson's disease	0.000263	0.00045	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—DRD2—Parkinson's disease	0.00026	0.000444	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—HTR7—Parkinson's disease	0.00026	0.000444	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—DRD1—Parkinson's disease	0.000259	0.000443	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000258	0.000441	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—DRD3—Parkinson's disease	0.000257	0.000439	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—GSTA4—Parkinson's disease	0.000257	0.000439	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—PENK—Parkinson's disease	0.000253	0.000432	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—MAG—Parkinson's disease	0.000253	0.000432	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—DRD3—Parkinson's disease	0.000251	0.000429	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—HTR7—Parkinson's disease	0.00025	0.000427	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—DRD2—Parkinson's disease	0.00025	0.000427	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—HTR1A—Parkinson's disease	0.000249	0.000426	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—GFAP—Parkinson's disease	0.000248	0.000425	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—GRM4—Parkinson's disease	0.000248	0.000423	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—GRM5—Parkinson's disease	0.000246	0.00042	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—TAC1—Parkinson's disease	0.000245	0.000419	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR downstream signaling—EDN1—Parkinson's disease	0.000245	0.000419	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—DRD1—Parkinson's disease	0.000241	0.000411	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.00024	0.00041	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—PENK—Parkinson's disease	0.000235	0.000401	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—MAG—Parkinson's disease	0.000235	0.000401	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000234	0.0004	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—DRD3—Parkinson's disease	0.000233	0.000398	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—HTR7—Parkinson's disease	0.000232	0.000397	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—DRD2—Parkinson's disease	0.000232	0.000397	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—PLA2G6—Parkinson's disease	0.000231	0.000395	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—PDYN—Parkinson's disease	0.000231	0.000395	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—FGF20—Parkinson's disease	0.000231	0.000394	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—EDN1—Parkinson's disease	0.000229	0.000391	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—MAOB—Parkinson's disease	0.000229	0.000391	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—HTR7—Parkinson's disease	0.000227	0.000388	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—DRD2—Parkinson's disease	0.000227	0.000388	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—ADORA2A—Parkinson's disease	0.000224	0.000382	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—EDN1—Parkinson's disease	0.000222	0.00038	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000218	0.000372	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—GFAP—Parkinson's disease	0.000217	0.000371	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—FGF20—Parkinson's disease	0.000215	0.000368	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—GRM5—Parkinson's disease	0.000215	0.000367	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—PDYN—Parkinson's disease	0.000215	0.000367	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000214	0.000366	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—HTR7—Parkinson's disease	0.000211	0.00036	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—DRD2—Parkinson's disease	0.000211	0.00036	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—CYP2D6—Parkinson's disease	0.000209	0.000358	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—ADORA2A—Parkinson's disease	0.000209	0.000357	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—EDN1—Parkinson's disease	0.000208	0.000355	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—INSR—Parkinson's disease	0.000206	0.000353	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—CTGF—Parkinson's disease	0.000205	0.000351	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—GFAP—Parkinson's disease	0.000202	0.000345	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—HTR2A—Parkinson's disease	0.0002	0.000342	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—EDN1—Parkinson's disease	0.0002	0.000342	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—GRM5—Parkinson's disease	0.0002	0.000341	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—FGB—Parkinson's disease	0.000195	0.000333	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—HTR2A—Parkinson's disease	0.000195	0.000333	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—HTR1A—Parkinson's disease	0.000194	0.000332	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—INSR—Parkinson's disease	0.000193	0.000329	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—CYP2E1—Parkinson's disease	0.000191	0.000327	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—TAC1—Parkinson's disease	0.000191	0.000327	CbGpPWpGaD
Levonordefrin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.000191	0.000326	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—NQO1—Parkinson's disease	0.000189	0.000324	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—FGF20—Parkinson's disease	0.000188	0.000322	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—DRD1—Parkinson's disease	0.000187	0.00032	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—TH—Parkinson's disease	0.000187	0.000319	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—EDN1—Parkinson's disease	0.000186	0.000318	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—ADORA2A—Parkinson's disease	0.000183	0.000312	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—FGB—Parkinson's disease	0.000182	0.000311	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—HTR2A—Parkinson's disease	0.000182	0.000311	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—EDN1—Parkinson's disease	0.000182	0.00031	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—DRD3—Parkinson's disease	0.000181	0.00031	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—HTR1A—Parkinson's disease	0.000181	0.00031	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—CYCS—Parkinson's disease	0.000179	0.000306	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—TAC1—Parkinson's disease	0.000178	0.000305	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—DRD1—Parkinson's disease	0.000175	0.000299	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000175	0.000299	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—FGF20—Parkinson's disease	0.000175	0.000299	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—CYP2D6—Parkinson's disease	0.00017	0.000291	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—ADORA2A—Parkinson's disease	0.00017	0.00029	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—DRD3—Parkinson's disease	0.00017	0.00029	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—ADRBK1—Parkinson's disease	0.000169	0.00029	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—EDN1—Parkinson's disease	0.000169	0.000288	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—INSR—Parkinson's disease	0.000169	0.000288	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—CTGF—Parkinson's disease	0.000167	0.000285	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—DRD2—Parkinson's disease	0.000164	0.000281	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—HTR7—Parkinson's disease	0.000164	0.000281	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000163	0.000278	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—FGB—Parkinson's disease	0.000159	0.000272	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—HTR2A—Parkinson's disease	0.000159	0.000272	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—COMT—Parkinson's disease	0.000159	0.000271	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—HTR1A—Parkinson's disease	0.000158	0.000271	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—ADRBK1—Parkinson's disease	0.000158	0.000271	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—GSTP1—Parkinson's disease	0.000158	0.00027	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—MAOA—Parkinson's disease	0.000158	0.000269	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—INSR—Parkinson's disease	0.000157	0.000268	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—TAC1—Parkinson's disease	0.000156	0.000267	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—HMOX1—Parkinson's disease	0.000156	0.000266	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—CYP2E1—Parkinson's disease	0.000156	0.000266	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—NQO1—Parkinson's disease	0.000154	0.000263	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—DRD2—Parkinson's disease	0.000153	0.000262	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—HTR7—Parkinson's disease	0.000153	0.000262	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—DRD1—Parkinson's disease	0.000153	0.000262	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—TH—Parkinson's disease	0.000152	0.000259	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—ABCB1—Parkinson's disease	0.000149	0.000255	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—DRD3—Parkinson's disease	0.000148	0.000253	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—FGB—Parkinson's disease	0.000148	0.000253	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—HTR2A—Parkinson's disease	0.000148	0.000252	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—HTR1A—Parkinson's disease	0.000147	0.000252	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—CYCS—Parkinson's disease	0.000146	0.000249	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—GSTM1—Parkinson's disease	0.000145	0.000248	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—TAC1—Parkinson's disease	0.000145	0.000248	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—DRD1—Parkinson's disease	0.000142	0.000243	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—GPX1—Parkinson's disease	0.000139	0.000238	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—ADRBK1—Parkinson's disease	0.000138	0.000237	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—DRD3—Parkinson's disease	0.000138	0.000235	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—IGF2—Parkinson's disease	0.000138	0.000235	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—DRD2—Parkinson's disease	0.000134	0.000229	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—HTR7—Parkinson's disease	0.000134	0.000229	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—IGF1R—Parkinson's disease	0.000133	0.000227	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—EDN1—Parkinson's disease	0.000131	0.000225	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—COMT—Parkinson's disease	0.000129	0.00022	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—ADRBK1—Parkinson's disease	0.000129	0.00022	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—IGF2—Parkinson's disease	0.000128	0.00022	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—GSTP1—Parkinson's disease	0.000128	0.000219	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—MTHFR—Parkinson's disease	0.000128	0.000219	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—MAOA—Parkinson's disease	0.000128	0.000219	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—HMOX1—Parkinson's disease	0.000126	0.000216	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—HTR7—Parkinson's disease	0.000125	0.000213	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—DRD2—Parkinson's disease	0.000125	0.000213	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—IGF1R—Parkinson's disease	0.000124	0.000212	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—EDN1—Parkinson's disease	0.000123	0.00021	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—ABCB1—Parkinson's disease	0.000121	0.000208	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—NGF—Parkinson's disease	0.000121	0.000206	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—APOE—Parkinson's disease	0.000119	0.000204	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—GSTM1—Parkinson's disease	0.000118	0.000201	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—HTR2A—Parkinson's disease	0.000115	0.000196	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—GPX1—Parkinson's disease	0.000113	0.000193	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—NGF—Parkinson's disease	0.000113	0.000193	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—IGF2—Parkinson's disease	0.000112	0.000192	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—IGF1R—Parkinson's disease	0.000109	0.000186	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—HTR2A—Parkinson's disease	0.000107	0.000184	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—EDN1—Parkinson's disease	0.000107	0.000183	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—APOE—Parkinson's disease	0.000107	0.000183	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—IGF2—Parkinson's disease	0.000104	0.000178	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—MTHFR—Parkinson's disease	0.000104	0.000178	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—INS—Parkinson's disease	0.000102	0.000174	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—IGF1R—Parkinson's disease	0.000101	0.000172	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—APOE—Parkinson's disease	9.98e-05	0.000171	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—EDN1—Parkinson's disease	9.97e-05	0.00017	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—NGF—Parkinson's disease	9.86e-05	0.000169	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—APOE—Parkinson's disease	9.7e-05	0.000166	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—HTR2A—Parkinson's disease	9.39e-05	0.00016	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—NGF—Parkinson's disease	9.16e-05	0.000157	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—INS—Parkinson's disease	9.13e-05	0.000156	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—APOE—Parkinson's disease	8.73e-05	0.000149	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—HTR2A—Parkinson's disease	8.72e-05	0.000149	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—INS—Parkinson's disease	8.53e-05	0.000146	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—INS—Parkinson's disease	8.28e-05	0.000142	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—APOE—Parkinson's disease	8.11e-05	0.000139	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—INS—Parkinson's disease	7.46e-05	0.000127	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—INS—Parkinson's disease	6.93e-05	0.000118	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—CASP3—Parkinson's disease	6.8e-05	0.000116	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—IL6—Parkinson's disease	6.75e-05	0.000115	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—CASP3—Parkinson's disease	6.35e-05	0.000109	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—IL6—Parkinson's disease	6.31e-05	0.000108	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—MAPK8—Parkinson's disease	6.25e-05	0.000107	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—MAPK8—Parkinson's disease	5.84e-05	9.97e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—CASP3—Parkinson's disease	5.55e-05	9.49e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—IL6—Parkinson's disease	5.51e-05	9.43e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—CASP3—Parkinson's disease	5.16e-05	8.82e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—IL6—Parkinson's disease	5.12e-05	8.76e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—MAPK8—Parkinson's disease	5.1e-05	8.72e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—MAPK8—Parkinson's disease	4.74e-05	8.1e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—IL6—Parkinson's disease	3.99e-05	6.82e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—IL6—Parkinson's disease	3.73e-05	6.37e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—IL6—Parkinson's disease	3.26e-05	5.57e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—IL6—Parkinson's disease	3.03e-05	5.17e-05	CbGpPWpGaD
